Literature DB >> 15752201

Evidence for non-enzymatic glycosylation of Escherichia coli chromosomal DNA.

Roumyana Mironova1, Toshimitsu Niwa, Yordan Handzhiyski, Angelina Sredovska, Ivan Ivanov.   

Abstract

We have recently shown that the process of non-enzymatic glycosylation (glycation) takes place in Escherichia coli under physiological conditions and affects both recombinant and endogenous bacterial proteins. In this study, we further demonstrate that E. coli chromosomal DNA is also subjected to glycation under physiological growth conditions. The E. coli DNA accumulates early glycation (Amadori) products as proven by the nitroblue tetrazolium (NBT) reduction assay. It showed also immunoreactivity to a monoclonal antibody raised against N(in)-(carboxymethyl)lysine and fluorescent properties indicative of modifications with advanced glycation end-products. Two types of fluorophores were detected in the E. coli DNA with excitation maxima at 360 nm and 380 nm and emission maxima at 440 nm and 410 nm. Using the NBT reduction assay, fluorescence spectroscopy and enzyme-linked immunosorbent assay we revealed that glycation adducts accumulate in DNA predominantly in the stationary phase of growth, although they could be detected also in exponential-phase cells. Besides on the growth phase, the extent of DNA glycation depends also on the nutrient broth composition being more extensive in rich media. Thiamine was found to inhibit both DNA glycation and spontaneous point mutations as judged by the decreased rate of the argE3 to Arg(+) reversions in the E. coli strain AB1157.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752201     DOI: 10.1111/j.1365-2958.2005.04504.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  13 in total

Review 1.  Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies.

Authors:  Sudhir Sahdev; Sunil K Khattar; Kulvinder Singh Saini
Journal:  Mol Cell Biochem       Date:  2007-09-12       Impact factor: 3.396

2.  Genetic control of amadori product degradation in Bacillus subtilis via regulation of frlBONMD expression by FrlR.

Authors:  Veronika Maria Deppe; Stephanie Klatte; Johannes Bongaerts; Karl-Heinz Maurer; Timothy O'Connell; Friedhelm Meinhardt
Journal:  Appl Environ Microbiol       Date:  2011-03-11       Impact factor: 4.792

3.  Rich Medium Composition Affects Escherichia coli Survival, Glycation, and Mutation Frequency during Long-Term Batch Culture.

Authors:  Karin E Kram; Steven E Finkel
Journal:  Appl Environ Microbiol       Date:  2015-04-24       Impact factor: 4.792

4.  Antiglycation effects of carnosine and other compounds on the long-term survival of Escherichia coli.

Authors:  Evan D Pepper; Michael J Farrell; Gary Nord; Steven E Finkel
Journal:  Appl Environ Microbiol       Date:  2010-10-15       Impact factor: 4.792

5.  Links between Disease Severity, Bacterial Infections and Oxidative Stress in Cystic Fibrosis.

Authors:  Sabina Galiniak; Mateusz Mołoń; Marta Rachel
Journal:  Antioxidants (Basel)       Date:  2022-04-29

6.  Culture volume and vessel affect long-term survival, mutation frequency, and oxidative stress of Escherichia coli.

Authors:  Karin E Kram; Steven E Finkel
Journal:  Appl Environ Microbiol       Date:  2013-12-27       Impact factor: 4.792

7.  Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products.

Authors:  Saheem Ahmad; Uzma Shahab; Mohd Hassan Baig; Mohd Sajid Khan; M Salman Khan; A K Srivastava; Mohd Saeed
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

Review 8.  The recombinant expression systems for structure determination of eukaryotic membrane proteins.

Authors:  Yuan He; Kan Wang; Nieng Yan
Journal:  Protein Cell       Date:  2014-08-15       Impact factor: 14.870

9.  Oxidative modification of proteins in pediatric cystic fibrosis with bacterial infections.

Authors:  Izabela Sadowska-Bartosz; Sabina Galiniak; Grzegorz Bartosz; Marta Rachel
Journal:  Oxid Med Cell Longev       Date:  2014-04-03       Impact factor: 6.543

10.  Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma.

Authors:  Elena Krachmarova; Ivan Ivanov; Genoveva Nacheva
Journal:  Microb Cell Fact       Date:  2020-07-11       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.